论文信息 - Treatment of active ankylosing spondylitis with pamidronate. - 字舞流文

Treatment of active ankylosing spondylitis with pamidronate.

J. Braun | J. Brandt | J. Sieper | H. Haibel | M. Rudwaleit | H. Soerensen | J. Braun

[1] A. Urtti,et al. Effect of Liposomal and Free Bisphosphonates on the IL-1β, IL-6 and TNFα Secretion from RAW 264 Cells in Vitro , 1995, Pharmaceutical Research.

[2] G. Jhangri,et al. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. , 2002, Arthritis and rheumatism.

[3] A. Schuerwegh,et al. Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. , 2001, Clinical and experimental rheumatology.

[4] G. Jhangri,et al. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. , 2001, The Journal of rheumatology.

[5] G. Jhangri,et al. An open study of pamidronate in the treatment of refractory ankylosing spondylitis. , 1998, The Journal of rheumatology.

[6] J. Ware,et al. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.